Rhodobacter sphaeroides diphosphoryl lipid A inhibits interleukin-6 production in CD14-negative murine marrow stromal ST2 cells stimulated with lipopolysaccharide or paclitaxel (taxol)
Restricted accessOtherFirst published online April, 1997
Rhodobacter sphaeroides diphosphoryl lipid A inhibits interleukin-6 production in CD14-negative murine marrow stromal ST2 cells stimulated with lipopolysaccharide or paclitaxel (taxol)
Paclitaxel (taxol), a microtubule stabilizer with anticancer activity, mimics the actions of lipopolysaccharide (LPS) on murine macrophages in vitro. Recent studies have shown that the Rhodobacter sphaeroides diphosphoryl lipid A (RsDPLA) inhibits both LPS- and paclitaxel-induced activation of murine macrophages, and have suggested that LPS, RsDPLA, and paclitaxel share the same receptor site on murine macrophages. To analyze this receptor site, the present study focused on the interactions between LPS, RsDPLA and paclitaxel in the activation of ST2 cells derived from murine bone marrow stroma. The ST2 cells did not express CD14 mRNA. The cells produced IL-6 molecules and expressed IL-6 mRNA in response to LPS, but did not produce TNF and nitric oxide. Paclitaxel induced IL-6 mRNA expression in ST2 cells. RsDPLA inhibited both LPS- and paclitaxel-induced IL-6 mRNA expression in a dose-dependent manner. These results suggest that LPS, RsDPLA, and paclitaxel are recognized by the same receptor complex on ST2 cells, and that the receptor functions without membrane CD14.
Get full access to this article
View all access options for this article.
References
1.
Morrison D.C. , Ryan J.L.Endotoxins and disease mechanisms. Annu Rev Med1987; 38: 417-432.
2.
Raetz C.R.H. , Ulevitch R.J., Wright S.D., Sibley C.H., Ding A., Nathan C.F.Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J1991; 5: 2652-2660.
Rietschel E.T. , Kirikae T., Schade F.U. et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J1994; 8: 217-225.
5.
Wright S.D., Jong M.C.Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J Exp Med1986; 164: 1876-1888.
6.
Hampton R.Y. , Golenbock D.T., Marsha P., Krieger M., Raetz C.R.H.Recognition and plasma clearance of endotoxin by scavenger receptors. Nature1991; 352: 342-344.
7.
Lei M.-G., Morrison D.C.Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations. J Immunol1988; 141: 996-1005.
8.
Kirikae T., Kirikae F., Schade F.U. et al. Detection of lipopolysaccharide-binding proteins on membranes of murine lymphocyte and macrophages-like cell lines. FEMS Microbiol Immunol1991; 76: 327-336.
9.
Schumann R.R. , Leong S.R., Flaggs G.W. et al. Structure and function of lipopolysaccharide binding protein. Science1990; 249: 1429-1431.
10.
Wright S.D. , Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C.CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science1990 ; 249: 1431-1433.
11.
Ding A.H., Porteu F., Sanchez E., Nathan C.F.Shared actions of endotoxin and taxol on TNF receptors and TNF release . Science1990; 248: 370-372.
12.
Manthey C.L. , Vogel S.N.Taxol: a promising endotoxin research tool . J Endotoxin Res1994; 1: 189-198.
13.
Pazdur R., Kudelka A.P., Kavanagh JJ, Cohen P.R., Raber M.N.The taxoids: paclitaxel (taxol) and docetaxel (taxotere). Cancer Treat Rev1993; 19: 351-386.
14.
Kirikae F., Kirikae T., Qureshi N., Takayama K., Morrison D.C., Nakano, M.CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect Immun1995; 63: 486-492
15.
Bogdan C., Ding A.Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor a and interleukin-1 in macrophages. J Leukoc Biol1992; 52: 119-121.
Takayama K. , Qureshi N., Beutler B., Kirland TNDiphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide . Infect Immun1989; 57: 1336-1338.
18.
Strittmatter W., Weckesser J., Salimath P.V., Galanos C.Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023. J Bacteriol1983; 155: 153-158.
19.
Qureshi N., Honovich J.P., Hara H., Cotter R.J., Takayama K.Location of fatty acids in lipid A obtained from lipopolysaccharide of Rhodopseudomonas sphaeroides ATCC 17023. J Biol Chem1988; 263: 5502-5504.
20.
Qureshi N., Takayama K., Kurtz R.Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun1991; 59: 441-444.
21.
Qureshi N., Takayama K., Meyers K.C. et al. Chemical reduction of 3-oxo and unsaturated groups in fatty acids of diphosphoryl lipid A from the lipopolysaccharide of Rhodopseudomonas sphaeroides. Comparison of biological properties before and after reduction . J Biol Chem1991; 266: 6532-6538.
22.
Henrickson B.E., Perera P.Y., Qureshi N., Takayama K., Vogel S.N.Rhodopseudomonas sphaeroides lipid A derivatives block in vitro induction of tumor necrosis factor and endotoxin tolerance by smooth lipopolysaccharide and monophosphoryl lipid A. Infect Immun1992; 60: 4285-4290.
23.
Kirikae T., Schade F.U., Kirikae F., Qureshi N., Takayama K., Rietschel E.T.Diphosphoryl lipid A derived from the lipopolysaccharide (LPS) of Rhodobacter sphaeroides ATCC 17023 is a potent competitive LPS inhibitor in murine macrophage-like J774.1 cells. FEMS Immunol Med Microbiol1994 ; 9: 237-244.
24.
Golenbock D.T. , Hampton R.Y., Qureshi N., Takayama K., Raetz C.R.H.Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem1991; 266: 19490-19498.
25.
Salimath P.V. , Weckesser J., Strittmatter W., Mayer H.Structural studies on the non-toxic lipid A from Rhodopseudomonas sphaeroides ATCC 17023. Eur J Biochem1983; 136: 195-200.
26.
Pugin J., Schurer-Maly C-C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S.Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA1993; 90: 2744-2748.
27.
Haziot A., Rong G-W., Silver J., Goyert S.M.Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide . Jlmmunol1993; 151: 1500-1507.
28.
Loppnow H., Stelter F., Schbnbeck U. et al. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD 14 mRNA or endogenous membrane CD 14. Infect Immun1995; 63: 1020-1026.
29.
Patrick D., Betts J., Frey E.A., Prameya R., Dorovini-Zis K., Finlay B.B.Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cell via a serum-dependent cytotoxic pathway. J Infect Dis1992; 165: 865-872.
30.
Frey E.A., Miller D.S., Jahr T.G. et al. Soluble CD14 participates in the response of cells to lipopolysaccharide . J Exp Med1992; 176: 1665-1671.
31.
Obayashi T. , Tamura H., Tanaka S. et al. A new chromogenic endotoxin-specific assay using recombined Limulus coagulation enzymes and its clinical applications . Clin Chim Acta1985; 149: 55-65.
32.
Kirikae T., Kirikae F., Oghiso Y., Nakano M.Microtubule-disrupting agents inhibit nitric oxide production in murine peritoneal macrophages stimulated with lipopolysaccharide or paclitaxel (taxol) . Infect Immun1996; 64: 3379-3384.
33.
Setoguchi M. , Nasu N., Yoshida S., Higuchi Y., Akizuki S., Yamamoto S. Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones. Biochim Biophys Acta1989 ; 1008: 213-222.
34.
Van Snick J. , Cayphas S., Szikora J.P. et al. cDNA cloning of murine interleukin-HP 1: homology with human interleukin 6. Eur J Immunol1988; 18: 193-197.
35.
Nishikawa S.-I. , Ogawa M., Nishikawa S., Kunisada T., Kodama H.B lymphopoiesis on stromal cell clone: stromal cell clones acting on different stages of B cell differentiation. Eur J Immunol1988; 18: 1767-1771.
Kirikae T., Schade F.U., Zähringer U. et al. The significance of the hydrophilic backbone and the hydrophobic fatty acid regions of lipid A for macrophage binding and cytokine induction . FEMS Immunol Med Microbiol1994; 8: 13-26.
38.
Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R.Analysis of nitrate, nitrite, and [15N]-nitrate in biological fluids . Anal Biochem1982; 126: 131-138.
39.
Ding A., Sanchez E., Nathan C.F.Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J Immunol1993; 151: 5596-5602.
40.
Dmg A., Chen B., Fuortes M., Blum E.Association of mitogen-activated protein kinases with microtubules in mouse macrophages. J Exp Med1996; 183: 1899-1904.
41.
Henricson B.E. , Carboni J.M., Burkhardt A.L., Vogel S.N.LPS and taxol activate Lyn kinase autophosphorylation in Lps(n), but not in Lps(d), macrophages . Mol Med1995; 1: 428-435.
42.
Manthey C.L. , Brandes M.E., Perera P.Y., Vogel S.N.Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J Immunol1992; 149: 2459-2465.
43.
Manthey C.L. , Perera P.Y., Salkowski C.A., Vogel S.N.Taxol provides a second signal for murine macrophage tumoricidal activity. J Immunol1994; 152: 825-831.
Nasu N., Yoshida S., Akizuki S., Higuchi Y., Setoguchi M., Yamamoto S.Molecular and physiological properties of murine CD14. Int Immunol1991; 3: 205-213.
47.
Goyert S.M. , Ferrero E., Rettig W.J., Yenamanda A.K., Obata F., LeBeau M.M.The CD 14 monocyte differentiation antigen maps to a region encoding growth factors and receptors . Science1988; 239: 497-500.
48.
Haziot A., Chen S., Ferrero E., Low M.G., Silver J., Goyert S.M.The monocyte differentiation antigen, CD 14, is anchored to the cell membrane by a phosphatidyl-inositol linkage. J Immunol1988; 141: 547-552.
49.
Kirikae T., Schade F.U., Kirikae F., Rietchel E.T., Morrison D.C.Isolation of a macrophage-like cell line defective in binding of lipopolysaccharide. Influence of serum and lipopolysaccharide chain length on macrophage activation . J Immunol1993; 151: 2742-2752.
50.
Ding A., Sanchez E., Tancinco M., Nathan C.Interactions of bacterial lipopolysaccharide with microtubule proteins . J Immunol1992; 148: 2853-2858.
51.
Pamess J., Horwit S.B.Taxol binds to polymerized tubulin in vitro. J Cell Biol1981; 91: 479-487.
52.
Rao S., Krauss E., Heerding J.M. et al. 3'-(ρ-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of β-tubulin. J Biol Chem1994; 269: 3132-3134.
53.
Nogales E., Wolf S.G., Khan LA, Ludueña R.F., Dowing K.H.Structure of tubulin at 6.5 A and location of the taxol-binding site . Nature1995; 375: 424-427.
54.
Kirikae T., Ojima I., Kirikae F. et al. Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophages. Biochem Biophys Res Commun1996; 227: 227-235.
55.
Delude R.L. , Savedra J.R., Zhao H. et al. CD14 enhances cellular responses to endotoxin with imparting ligand-specific recognition . Proc Natl Acad Sci USA1995; 92: 9288-9292.
56.
Lei M-G., Qureshi N., Morrison D.C.Lipopolysaccharide (LPS) binding to 73-kDa and 38-kDa surface proteins on lymphoreticular cells: preferential inhibition of LPS binding to the former by Rhodopseudomonas sphaeroides lipid A. Immunol Lett1993; 36: 245-250.
